KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Takeda Pharmaceutical (TAK) Exchange Rate Effect (2018 - 2025)

Historic Exchange Rate Effect for Takeda Pharmaceutical (TAK) over the last 8 years, with Q4 2025 value amounting to $145.8 million.

  • Takeda Pharmaceutical's Exchange Rate Effect fell 310.85% to $145.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $156.1 million, marking a year-over-year increase of 19880.71%. This contributed to the annual value of -$74.7 million for FY2025, which is 14113.38% down from last year.
  • According to the latest figures from Q4 2025, Takeda Pharmaceutical's Exchange Rate Effect is $145.8 million, which was down 310.85% from $90.7 million recorded in Q3 2025.
  • Takeda Pharmaceutical's 5-year Exchange Rate Effect high stood at $229.6 million for Q1 2021, and its period low was -$280.1 million during Q3 2024.
  • In the last 5 years, Takeda Pharmaceutical's Exchange Rate Effect had a median value of $62.7 million in 2024 and averaged $49.1 million.
  • Its Exchange Rate Effect has fluctuated over the past 5 years, first skyrocketed by 1035893.82% in 2022, then plummeted by 111136.78% in 2024.
  • Takeda Pharmaceutical's Exchange Rate Effect (Quarter) stood at $54.1 million in 2021, then tumbled by 225.38% to -$67.8 million in 2022, then surged by 68.92% to -$21.1 million in 2023, then surged by 814.13% to $150.5 million in 2024, then decreased by 3.11% to $145.8 million in 2025.
  • Its Exchange Rate Effect was $145.8 million in Q4 2025, compared to $90.7 million in Q3 2025 and -$16.8 million in Q2 2025.